Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
20 hedge funds and large institutions have $2.4M invested in Orgenesis Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 1 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
0% more funds holding
Funds holding: 20 → 20 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
20% less capital invested
Capital invested by funds: $3.02M → $2.4M (-$618K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RAM
Redmond Asset Management
Henrico,
Virginia
|
+$865K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$9.39K |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$4.88K |
| 4 |
JP Morgan Chase
New York
|
+$3.81K |
| 5 |
BlackRock
New York
|
+$2.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$29.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$10.7K |
| 3 |
Renaissance Technologies
New York
|
-$2.44K |
| 4 |
Morgan Stanley
New York
|
-$282 |
ORGS Hedge Fund Activity: Q1 2023 in Review
20 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q1 2023, worth a combined $2.4M — down 20% from $3.02M a quarter earlier.
Fund positioning in ORGS was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 7 added to existing stakes and 3 trimmed.
The largest buyer was Redmond Asset Management, opening a new position worth an estimated $865K. The largest seller was Citadel Advisors, exiting entirely with an estimated $29.9K sold.
- 20 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $2.4M of Orgenesis Inc. Common Stock stock for Q1 2023, down 20% quarter-over-quarter.
- 1 fund opened new Orgenesis Inc. Common Stock positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q1 2023 was Redmond Asset Management, an estimated $865K added.
- The largest Orgenesis Inc. Common Stock seller in Q1 2023 was Citadel Advisors, an estimated $29.9K sold.
Based on aggregated 13F filings for Q1 2023.